Paper Details
- Home
- Paper Details
Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity.
Author: FutchBrittany G, LadShivanand P, LeeHui-Jie, ParenteBeth A, SpearsCharis A, VenkatramanVishal, YangLexie Z
Original Abstract of the Article :
Chronic spasticity causes significant impairment and financial burden. Oral baclofen, the first-line therapy, can have intolerable, dose-dependent side effects. Targeted drug delivery (TDD) through intrathecal baclofen delivers smaller amounts of baclofen into the thecal sac via an implanted infusio...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://pubmed.ncbi.nlm.nih.gov/36890089
データ提供：米国国立医学図書館（NLM）
Targeted Drug Delivery for Spasticity: A Desert Oasis of Cost-Effectiveness
Spasticity, a neurological condition, can significantly impact a patient's mobility and quality of life. This study, like a skilled financial analyst assessing the cost-effectiveness of different treatment options, investigates the healthcare costs and baclofen use associated with targeted drug delivery (TDD) for spasticity. The researchers, like seasoned financial advisors, are seeking to optimize treatment strategies, balancing efficacy with cost-effectiveness, ultimately leading to improved patient outcomes.
TDD: A Desert Oasis of Cost-Effectiveness for Spasticity?
This study, like a detailed financial report, explores the costs and resource utilization associated with TDD for spasticity. The researchers, like meticulous accountants, meticulously track healthcare costs and baclofen use, highlighting the potential for cost savings with TDD. This research, like a valuable tool in a resource-constrained environment, provides valuable information for clinicians and healthcare decision-makers seeking to optimize treatment strategies for spasticity.
Navigating the Desert of Spasticity Treatment
This study, like a map guiding travelers through a diverse landscape, provides valuable insights into the cost-effectiveness of TDD for spasticity. By understanding the financial implications of different treatment options, clinicians can better navigate the complex world of spasticity management, ultimately leading to more informed decisions and improved outcomes for patients.
Dr. Camel's Conclusion
This research, like a well-equipped oasis offering both treatment and cost-effectiveness, highlights the potential of TDD to improve the management of spasticity. By understanding the financial implications of different treatment options, we can navigate the challenging desert of spasticity with greater precision and provide more affordable and effective care for those seeking relief.
Date :
- Date Completed 2023-08-07
- Date Revised 2023-08-23
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.